Guideline Central

09/15/2026

Recently published clinical guidelines on interstitial lung disease from societies including the American Thoracic Society (ATS), European Respiratory Society (ERS), and others.

Today, we have a rundown of the most recently published clinical guidelines on interstitial lung disease from societies including the American Thoracic Society (ATS), European Respiratory Society (ERS), and others.

09/15/2026

The 2026 Management of Cardiovascular Disease and Chronic Kidney Disease guideline, highlighting key messages across screening, risk assessment, management, and more. https://www.guidelinecentral.com/insights/sep-2026-esc-managementofcardiovasculardiseaseandckd-guideline-video/

09/15/2026

The 2026 guideline update to the NICE guideline, Psychosis and in Adults.

Today, we are taking a look at the 2026 guideline update to the NICE guideline, Psychosis and Schizophrenia in Adults.

09/14/2026

The IDSA guideline Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients.

Today, we are taking a look at the IDSA guideline Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients.

09/14/2026

In girls ages 6.0 to 8.0 years and boys ages 8.0 to 9.0 years with central precocious puberty and without central nervous system findings, the Endocrine Society suggests that brain MRI should not be routinely performed.

This recommendation does not apply to younger patients or to patients of any age who present with CNS findings (eg, headaches, seizures, and/or visual field deficits).

https://www.guidelinecentral.com/guideline/5214494/

09/14/2026

The American Academy of Pediatrics recently released a policy statement regarding the prevention of in infants and children.

The American Academy of Pediatrics recently released a policy statement regarding the prevention of RSV in infants and children.

09/14/2026

Weekly medication recap going over new FDA medication approvals and indications for Hyrnuo, Joenja, and Isembyld.
https://www.guidelinecentral.com/drugs/

09/14/2026

Weekly guideline recap with guideline and consensus statement updates from WHO, ACMG, AGA, AHA, ASTCT, ASNC, AACE, and AUA/SUO.
https://www.guidelinecentral.com/guidelines/

09/12/2026

The latest guideline from the AAD, specifically the Diagnostic Testing in Adults with Presumed Atopic Refractory to Treatment.

Today, we have a look at the latest guideline from the AAD, specifically the Diagnostic Testing in Adults with Presumed Atopic Dermatitis Refractory to Treatment.

09/12/2026

The AAP recently released its 2026-2027 policy statement regarding COVID-19 vaccines for infants, children, and adolescents.

The AAP recently released its 2026-2027 policy statement regarding COVID-19 vaccines for infants, children, and adolescents.